2014 Equity Incentive Plan
Exhibit 10.3
2014 Equity Incentive Plan
The 2014 Equity Incentive Plan provides for the issuance of equity incentive awards in the form of (i) non-qualified stock options; and (ii) time-based restricted stock units.
Executive Officer | Time-Based Restricted Stock Units (# shares) | Non-Qualified Stock Options (# shares) | ||||||
Douglas Bryant President and Chief Executive Officer | 4,243 | 93,021 | ||||||
Robert Bujarski Senior Vice President, Business Development and General Counsel | 1,305 | 28,621 | ||||||
Mark Smits Senior Vice President, Commercial Operations, North America | 1,523 | 33,392 | ||||||
Timothy Stenzel Chief Scientific Officer | 725 | 15,901 | ||||||
Randall Steward Chief Financial Officer | 1,741 | 38,162 | ||||||
John Tamerius Senior Vice President, Clinical and Regulatory Affairs | 961 | 21,068 |
The vesting period for the non-qualified stock options and restricted stock units is over four years with the first 50% of such equity awards vesting at the end of the second-year anniversary of the grant date and the remainder vesting 25% annually on each of the following two anniversaries thereafter.